DAIC

DECEMBER 29, 2023

Outcomes of ablation with the FARAPULSE PFA System – a nonthermal treatment in which electric fields selectively ablate heart tissue – will be compared to outcomes following use of anti-arrhythmic drug (AAD) therapy, which is commonly prescribed for patients living with persistent AF. Circulation.

Atrial Fibrillation 115

Atrial Fibrillation Ablation Atrial Flutter Blood Clot 115

The New England Journal of Medicine

JANUARY 24, 2024

This article reviews the use of digital wearable technologies for monitoring of three common cardiovascular conditions: hypertension, heart failure, and atrial fibrillation.

Technology 72

Technology Atrial Fibrillation Article Heart Failure 72

Science Daily - Heart Disease

APRIL 22, 2024

Atrial fibrillation is the most common cardiac arrhythmia worldwide with around 59 million people concerned in 2019. Researchers have recently developed a deep-learning model capable of predicting the transition from a normal cardiac rhythm to atrial fibrillation.

Arrhythmia 119

Arrhythmia Atrial Fibrillation Dementia Heart Failure 119

DAIC

JULY 16, 2024

mtaschetta-millane Tue, 07/16/2024 - 09:47 July 16, 2024 — Ultrahuman, a pioneer in wearable technology , launches PowerPlugs, a platform for individual apps and plugins built on top of Ultrahuman’s health and wellness data stack. This is the world’s first in a smart ring form factor.

AFIB 105

AFIB Technology Heart Rhythm Arrhythmia 105

HeartRhythm

AUGUST 31, 2024

Atrial fibrillation (AF) is the most common cardiac arrhythmia. Smart technologies such as smartphones and smartwatches used in everyday life offer promising avenues for enhancing AF management.

Atrial Fibrillation 40

Atrial Fibrillation Technology Heart Rhythm Arrhythmia 40

HeartRhythm

MARCH 28, 2025

Rhythm control therapy and especially atrial fibrillation (AF) ablation are the focus of growing research in patients with AF. Novel technologies such as pulsed field ablation (PFA) may improve the safety and efficacy of AF ablation.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Quality of Life Technology 40

DAIC

JANUARY 29, 2025

16, 2025 Primary results from the DEFINE AFib clinical study show the Medtronic LINQ family of insertable cardiac monitors (ICM), paired with a novel algorithm, were able to detect atrial fibrillation episodes and properly risk stratify patients as high risk prior to an AF-related healthcare utilization 80% of the time. 2024, May 15).

AFIB 52

AFIB Atrial Fibrillation Quality of Life Heart Rhythm 52

MIBHS

JANUARY 31, 2025

In the age of technology, wearable devices have revolutionized how we approach health and wellness. This blog explores the ways wearable technology can help track heart health, the advantages it offers, and how it contributes to better outcomes for those requiring surgical intervention.

Heart Rhythm 52

Heart Rhythm Technology AFIB Exercise 52

HeartRhythm

JULY 21, 2024

The global health challenge posed by cardiac arrhythmias, particularly atrial fibrillation (AF), is significant, with heightened risks of stroke, heart failure, and systemic embolism1. Traditional arrhythmia detection has often missed transient or asymptomatic episodes, relying on symptomatic presentations and episodic monitoring.

Technology 45

Technology Arrhythmia Atrial Fibrillation Heart Failure 45

DAIC

JUNE 4, 2024

Penn Presbyterian Medical Center Becomes First Hospital in the Northeast to Adopt Advanced Robotic Technology for Heart Treatment 5. Late-breaking Clinical Trial Results from FARADISE, admIRE Study and Advent Trial at Heart Rhythm 2024 Highlight Pulsed Field Ablation Developments for Atrial Fibrillation Treatment 8.

Preserved Ejection Fraction 105

Preserved Ejection Fraction Peripheral Arterial Disease Heart Failure Atrial Fibrillation 105

Frontiers in Cardiovascular Medicine

MAY 1, 2024

BackgroundCatheter ablation is frequently used to manage recurrent atrial fibrillation (AF) resistant to drug therapy, with pulmonary vein isolation (PVI) as a key tactic. The reconnection of pulmonary veins was discovered primarily in the anterior region of the right superior PV and the superior portion of the left superior PV.

Atrial Fibrillation 52

Atrial Fibrillation Ablation Pulmonary Technology 52

HeartRhythm

MARCH 12, 2024

We are diagnosing atrial fibrillation (AF) more often that at any time in history. This is driven by the aging of our populations, the growing prevalence of AF risk factors and by the proliferation of longer-term electrocardiographic monitoring, including patient-facing technologies 1,2.

Atrial Fibrillation 45

Atrial Fibrillation Stroke Strokes Risk Factors 45

HeartRhythm

SEPTEMBER 23, 2024

Atrial fibrillation (AF) is the most common arrhythmia worldwide, with increasing prevalence resulting from improved awareness, increased life expectancy, and advances in detection technology.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Heart Rhythm Electrophysiology 40

HeartRhythm

APRIL 30, 2024

The absence of TAR has hindered successful LAT mapping during atrial fibrillation (AF). TARLess, a novel technology enabling LAT mapping without TAR, shows promise for advancing AF activation mapping.

Atrial Fibrillation 40

Atrial Fibrillation Technology 40

DAIC

FEBRUARY 2, 2024

Titled "Real-world Data Affirms Safety and Effectiveness of Low/Zero Fluoroscopy Atrial Fibrillation Ablation," the study was presented as a late-breaker at the 29th Annual International AF Symposium. Real-world Data Affirms Safety and Effectiveness of Low/Zero Fluoroscopy Atrial Fibrillation Ablation [abstract].

Ablation 105

Ablation Atrial Fibrillation AFIB Heart Rhythm 105

HeartRhythm

APRIL 30, 2024

Omnipolar technology near-field (OTNF) is an emerging cardiac mapping approach and may provide insights into electroanatomical substrate mapping during atrial fibrillation (AF) ablation.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Technology 40

HeartRhythm

AUGUST 21, 2024

No data have been reported on cooling characteristics and the impact of variant pulmonary vein (PV) anatomy on atrial fibrillation (AF) recurrences after POLARx cryoballoon (CB) ablation.

Anatomy 40

Anatomy Atrial Fibrillation Pulmonary Ablation 40

DAIC

FEBRUARY 27, 2024

Bernard's Heart & Vascular Center , Jonesboro, Arkansas) mark a significant milestone in the pursuit of innovative solutions for non-valvular atrial fibrillation (NVAF) treatment. It's exciting to be part of the evolution of the latest technology into a tangible solution for treating patients.

Atrial Fibrillation 105

Atrial Fibrillation Innovation AFIB Pharmacology 105

Stroke Journal

NOVEMBER 21, 2023

Atrial fibrillation is a major cause of ischemic stroke. Technological advances now support prolonged cardiac rhythm monitoring using either surface electrodes or insertable cardiac monitors. Furthermore, the clinical significance of very short duration paroxysmal atrial fibrillation remains controversial.

Atrial Fibrillation 40

Atrial Fibrillation Stroke Strokes Technology 40

Journal of Cardiovascular Electrophysiology

OCTOBER 3, 2024

Abstract Introduction Atrial fibrillation (Afib) is a prevalent chronic arrhythmia associated with severe complications, including stroke, heart failure, and increased mortality. Despite ethical considerations and disparities, the potential benefits outweigh the challenges.

Atrial Fibrillation 40

Atrial Fibrillation AFIB Technology Heart Failure 40

HeartRhythm

SEPTEMBER 9, 2024

Pulsed field ablation (PFA) for the treatment of paroxysmal atrial fibrillation (AF) was validated to be safe and effective.1 Widespread adoption of this potentially transformative technology has brought into the focus the economics of AF with new therapies requiring significant capital and disposable investment.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Technology 40

DAIC

JULY 17, 2024

The present invention relates to medical methods for transseptal access to the heart using steerable introducers based on the Company’s Morph DNA technology. This additional patent protection for BioCardia’s current and future products in this important existing market enhances shareholder value.

Myocardial Infarction 105

Myocardial Infarction Atrial Fibrillation Technology Angina 105

Frontiers in Cardiovascular Medicine

DECEMBER 19, 2023

Background The rising adoption of wearable technology increases the potential to identify arrhythmias. Herein, we report results of a follow-up screening protocol for incident atrial fibrillation/flutter (AF) within a large observational digital health study.

Blood Pressure 64

Blood Pressure Atrial Fibrillation AFIB Arrhythmia 64

HeartRhythm

APRIL 30, 2024

Pulsed field ablation (PFA) and very-high power short-duration (vHPSD) radiofrequency ablation are the most recently introduced technologies for atrial fibrillation (AF) ablation. The procedural performance, safety, and effectiveness of PFA versus vHPSD are currently unknown.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Technology 40

HeartRhythm

NOVEMBER 5, 2024

Pulsed field ablation (PFA) is a safe and effective technology for catheter ablation of atrial fibrillation (AF). Multiple PFA-platforms for AF-ablation have been developed. However, evidence comparing the real-word implementation and performance of different PFA-systems is still limited.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Technology Outcomes 40

HeartRhythm

APRIL 30, 2024

Pulsed field ablation (PFA) has recently been introduced as a novel routine ablation technology for paroxysmal atrial fibrillation (AF). It is also used as off-label therapy for persistent AF.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Technology Pulmonary 40

HeartRhythm

APRIL 30, 2024

Atrial fibrillation (AF) catheter ablation trials report arrhythmia-free survival using different post-ablation rhythm monitoring protocols, resulting in difficulties in the interpretation of the recurrence rates and comparison of ablation strategies and technologies.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Technology Arrhythmia 40

HeartRhythm

AUGUST 31, 2024

Patients with CLL are at increased risk of developing atrial fibrillation (AF), however AF is a known side effect of ibrutinib therapy as well and is associated with worse outcomes. The incidence of atrial fibrillation (AF) is 10-15% with a median time to occurrence of 5-13 months.

Cardio Oncology 40

Cardio Oncology Technology Atrial Fibrillation Arrhythmia 40

HeartRhythm

APRIL 30, 2024

Pulmonary vein (PV) isolation is the cornerstone of radiofrequency (RF) ablation for atrial fibrillation (AF). Advances in catheter technology, ablation techniques, and ablation lesion metrics have resulted in improved PV isolation durability.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Pulmonary Technology 40

HeartRhythm

APRIL 30, 2024

Non-thermal pulsed field ablation (PFA) is an novel technology to perform pulmonary vein isolation (PVI) for atrial fibrillation (AF). Different PFA systems are available, but no comparative data exist.

Atrial Fibrillation 40

Atrial Fibrillation Pulmonary Ablation Technology 40

DAIC

JUNE 11, 2024

Innovation in medical technology exists to improve patient outcomes, increase surgical efficiency and enhance patient safety. Infrequently, we see medical technology innovation of a paradigmatic nature that changes the way physicians approach disease states and dramatically improve results.

Innovation 104

Innovation AFIB Technology Electrophysiology 104

HeartRhythm

APRIL 30, 2024

All of the PFA technologies in clinical use, or being studied in clinical trials employ microsecond-scale pulses. Thus, nanosecond PFA (nsPFA) might prove ideal for safe and highly effective lesions to treat atrial fibrillation.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Technology 40

DAIC

JANUARY 31, 2024

intermittent) atrial fibrillation (AF) and is a unique new alternative to standard-of-care thermal ablation treatment. intermittent) atrial fibrillation (AF) and is a unique new alternative to standard-of-care thermal ablation treatment. said Nick Spadea-Anello, president, Electrophysiology, Boston Scientific.

Ablation 111

Ablation Atrial Fibrillation Anatomy Pulmonary 111

HeartRhythm

AUGUST 31, 2024

Influence on patient behavior— namely changing ingrained, maladaptive behaviors for those with Atrial Fibrillation (AF)— lends itself to varied methodology due to evidence-based research.

Atrial Fibrillation 40

Atrial Fibrillation Technology Research 40

HeartRhythm

APRIL 9, 2024

Pulsed field ablation (PFA) is an innovative technology recently adopted for treating atrial fibrillation (AF). Preclinical and clinical studies have reported a reassuring safety profile because of its tissue-specific effect, sparing adjacent tissues.1

Atrial Fibrillation 40

Atrial Fibrillation Ablation Innovation Technology 40

HeartRhythm

APRIL 30, 2024

We have employed digital twin technology to perform extra pulmonary vein (PV) ablation in patients with non-paroxysmal atrial fibrillation (AF). We reported that high dominant frequency (DF) site ablation improved rhythm outcomes, but high maximal slope of action potential restitution curve (Smax) site ablation did not.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Technology Pulmonary 40

HeartRhythm

APRIL 30, 2024

The 1st generation HeartLight laser balloon (LB) ablation is highly effective in achieving pulmonary vein isolation (PVI), and the safety and 12-month efficacy are comparable with paroxysmal atrial fibrillation (PAF) ablation technologies.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Technology Pulmonary 40